New approaches in the pharmacological treatment of stress urinary incontinence

References 

1. Hannestad YS, Rortveit G, Sandvik H, Hannestad YS. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol. 2000;53:1150–1157
   • Abstract
   • Full Text
   • Full-Text PDF (1008 KB)
   • CrossRef
2. Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol. 2003;189:1275–1282
   • Abstract
   • Full Text
   • Full-Text PDF (151 KB)
   • CrossRef
3. Kinchen KS, Burgio K, Diokno AC, Fultz NH, Bump R, Obenchain R. Factors associated with women's decisions to seek treatment for urinary incontinence. J Women's Health. 2003;12:687–698
4. Minassian VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynecol Obstet. 2003;82:327–338
5. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstem U, et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178
   • MEDLINE
   • CrossRef
6. Contreras Ortiz O. Stress urinary incontinence in the gynecological practice. Int J Gynecol Obstet 2004;86(Suppl 1):S7–S17
7. Norton PA, MacDonald LD, Sedgwick PM, Stanton SL. Distress and delay associated with urinary incontinence, frequency, and urgency in women. Br Med J. 1988;297:1187–1189
8. Dwyer P. Differentiating stress urinary incontinence from urge urinary incontinence. Int J Gynecol Obstet 2004;86(Suppl 1):S19–S26
9. Sandvik H, Hunskaar S, Vanvik A, Bratt H, Seim A, Hermstad R. Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity. J Clin Epidemiol. 1995;48:339–343
   • Abstract
   • Full-Text PDF (464 KB)
   • CrossRef
10. Weidner AC, Myers ER, Visco AG, Candiff GW, Bump RC. Which women with stress incontinence require urodynamic evaluation?. Am J Obstet Gynecol. 2001;184:20–27
    • Abstract
    • Full Text
    • Full-Text PDF (66 KB)
    • CrossRef
11. Viktrup L, Bump RC. Pharmacological agents used for the treatment of stress urinary incontinence in women. Curr Med Res Opin. 2003;19:485–490
    • MEDLINE
    • CrossRef
12. Pesce F. Current management of stress urinary incontinence. Br Jr Urin Int 2004;19(Suppl 1):8–13
13. Hilton P. Trials of surgery for stress incontinence—thoughts on the ‘Humpty Dumpty principle’. Br J Obstet Gynecol. 2002;109:1081–1088
14. Black NA, Downs SH. The effectiveness of surgery for stress incontinence in women—a systematic review. Br J Urol. 1996;78:497–510
    • MEDLINE
15. Viktrup L, Summers KH, Dennett SL. Clinical practice guidelines for the initial management of urinary incontinence in women: a European-focused review. Int J Gynecol Obstet 2004;86(Suppl 1):S27–S39
16. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Snow JL, Thompson L, Nelson DL. Comparative affinity of duloxetine and venlafaxine for serotonin and norepineprine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25:871–880
    • MEDLINE
    • CrossRef
17. Thor K. Targeting serotonin and norepinephrine receptors in stress urinary incontinence. Int J Gynecol Obstet 2004;86(Suppl 1):S41–S55
18. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther. 1995;274:1014–1024
    • MEDLINE
19. Moore K. Duloxetine: a new approach for treating stress urinary incontinence. Int J Gynecol Obstet 2004;86(Suppl 1):S57–S66
20. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women (Cochrane review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software